2. Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas // Neurology, 2000; 54:71 – 76
5. Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarides M, Menei P, Deruty R, Moreau JJ, Fevre-Montange M, Guyotat J. WHO grade II and III meningiomas: a study of prognostic factors // J Neurooncol, 2009; 95:367 – 375
7. Louis, DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system, 4<sup>th</sup> ed. Lyon: IARC Press; 2007.
8. Mocker K, Holland H, Ahnert P, Schober R, Bauer M, Kirsten H, Koschny R, Meixensberger J, Krupp W. Multiple meningioma with different grades of malignancy: case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogenetics // Pathol Res Pract, 2011; 207:67 – 72
9. Violaris K, Katsarides V, Sakellariou P. The recurrence rate in meningiomas: analysis of tumor location, histological grading, and extent of resection // Open Journal of Modern Neurosurgery, 2012; 2:6 – 10